Trials / Conditions / Immune Complex Membranoproliferative Glomerulonephritis
Immune Complex Membranoproliferative Glomerulonephritis
3 registered clinical trials studyying Immune Complex Membranoproliferative Glomerulonephritis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN NCT03955445 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glo NCT03723512 | Mario Negri Institute for Pharmacological Research | N/A |
| Terminated | A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471 NCT03459443 | Alexion Pharmaceuticals, Inc. | Phase 2 |